• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS LUCERA ELITE GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS LUCERA ELITE GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-H290T
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Type  Injury  
Event Description
Olympus reviewed the following literature article: "original article efficacy of partial injection underwater endoscopic mucosal resection for superficial duodenal epithelial tumor: propensity score-matched study (with video)."     literature summary background and aim: underwater endoscopic mucosal resection (uemr) has been reported as effective endoscopic treatment for superficial duodenal epithelial tumors (sdets).However, it has been reported that a notable problem of uemr for sdets is that en bloc resection rate is relatively low.Therefore, we proposed a novel technique to improve en bloc resection rate: uemr combining partial submucosal injection (pi-uemr).The aim of this study is to evaluate efficacy and safety of pi-uemr for sdets by comparing to uemr.Methods: this is a retrospective observational study in a single center.The patients who underwent uemr or pi-uemr from june 2010 to august 2020 were included in this study.Eligible patients were selected from included patients in a 1:1 ratio using propensity score matching.The clinical outcomes of endoscopic resection (procedure time, en bloc resection rate, complication rate [immediate perforation, delayed bleeding, delayed perforation]), and histopathologicaldiagnosis (adenoma/cancer) were compared between each group.Results: two hundred and twenty-eight patients were included in this study.Of included patients, 47 patients were selected in each group by propensity score matching.There were no statistical differences in procedure time (11 + 1.2 min vs.9 ± 1.2 min, p = 0.30), complication rate (immediate perforation [0% vs.2%, p = 0.12], delayed bleeding [0% vs.2%, p = 0.12], and no delayed perforation) and histopathological diagnosis (adenoma; 100% vs.96%, p = 0.14) in each group.However, en bloc resection rate of pi-uemr was significantly higher than uemr (96% vs.83%, p < 0.05).Conclusion: partial submucosal injection uemr might be superior procedure for en bloc resection in sdets compare to uemr.The authors stated the intraoperative perforation was closed with endoscopy clips.The delayed bleeding was controlled by urgent endoscopy without blood transfusion.The authors used 3 different olympus devices for the following events: type of adverse events/number of patients: intraoperation perforation n=1, delayed bleeding n=1.  this article includes 3 reports: patient identifier (b)(6), 15 or 20mm, patient identifier (b)(6), patient identifier (b)(6).This report is 3 of 3 for patient identifier (b)(6).
 
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Manufacturer Narrative
This supplemental report is being submitted to provide additional information from the author and the legal manufacturer's investigation.Correction b1: after receiving additional information from the author, the adverse events reported in the literature article have been determined not to be serious injuries.The device history records (dhr) for this device could not be reviewed since the serial number was not provided.Olympus ships devices manufactured according to all applicable procedures and meet final product release criteria.A definitive root cause was not identified.Based on the available information, the legal manufacturer was unable to determine the probable cause of the adverse events since the device was not returned for evaluation.
 
Event Description
Additional information received from the author: in the opinion of the author, the olympus device did not cause or contribute to the adverse events reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA ELITE GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
Manufacturer Contact
kazutaka matsumoto
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8-507
JA   192-8507
426425177
MDR Report Key14375506
MDR Text Key293370156
Report Number8010047-2022-08138
Device Sequence Number1
Product Code FDS
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-H290T
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received05/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
SD-210L-10, 15 OR 20MM, LOT UNKNOWN
Patient Outcome(s) Required Intervention; Other;
-
-